Stifel Maintains Buy on RXO, Raises Price Target to $30

Benzinga Newsdesk www.benzinga.com Positive 59.1%

Neg 0% Neu 0% Pos 59.1%

Stifel analyst J. Bruce Chan maintains RXO (NYSE:RXO) with a Buy and raises the price target from $22 to $30.

Comments

No comments yet. Be the first!